← All trials
NCT06166615
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 15, 2023
- Primary completion
- May 30, 2024
- Completion date
- Nov 1, 2024
- First posted
- Dec 12, 2023
- Last posted
- Dec 12, 2023
- Enrollment
- 148
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Seoul National UniversityLead sponsor
- Seoul National UniversityOverall official - principal investigator
- Seoul National UniversityReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.